Artificial intelligence-based prediction of biochemical recurrence of prostate cancer using multiparametric mri: a critical narrative review
Artificial intelligence-powered mpMRI analysis holds substantial promise for non-invasive, accurate BCR prediction in PCa and integration of radiomics and DL with clinical and multi-omics data within standardized, multi-center frameworks represents the most promising future direction.